Cargando…
Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
The emergence outbreak caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has received significant attention on the global risks. Due to itscrucial role in viral replication, the main protease 3CL(pro) is an important target for drug discovery and development to combat CO...
Autores principales: | Somboon, Tuanjai, Mahalapbutr, Panupong, Sanachai, Kamonpan, Maitarad, Phornphimon, Lee, Vannajan Sanghiran, Hannongbua, Supot, Rungrotmongkol, Thanyada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832253/ https://www.ncbi.nlm.nih.gov/pubmed/33518853 http://dx.doi.org/10.1016/j.molliq.2020.114999 |
Ejemplares similares
-
Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
por: Sanachai, Kamonpan, et al.
Publicado: (2022) -
Computational Screening of Newly Designed Compounds against Coxsackievirus A16 and Enterovirus A71
por: Sripattaraphan, Amita, et al.
Publicado: (2022) -
Discovery of JAK2/3
Inhibitors from Quinoxalinone-Containing
Compounds
por: Sanachai, Kamonpan, et al.
Publicado: (2022) -
Insights into the Binding Recognition and Susceptibility
of Tofacitinib toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2020) -
Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein
por: Darai, Nitchakan, et al.
Publicado: (2022)